REPORT ID 3420

EMEA (Europe, Middle East and Africa) Telomerase Reverse Transcriptase Market Report 2017

Publish Date
13-Dec-17
Pages
111
Format
Electronic (PDF)

In this report, the EMEA Telomerase Reverse Transcriptase market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Pcs), revenue (Million USD), market share and growth rate of Telomerase Reverse Transcriptase for these regions, from 2012 to 2022 (forecast)
    Europe: Germany, France, UK, Russia, Italy and Benelux;
    Middle East: Saudi Arabia, Israel, UAE and Iran;
    Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Telomerase Reverse Transcriptase market competition by top manufacturers/players, with Telomerase Reverse Transcriptase sales volume (K Pcs), price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including
    Argos Therapeutics Inc
    Asterias Biotherapeutics Inc
    e-Therapeutics Plc
    F. Hoffmann-La Roche Ltd
    Inovio Pharmaceuticals Inc
    Invectys SA
    Johnson & Johnson
    Komipharm International Co Ltd
    Mediolanum farmaceutici SpA
    Telocyte LLC
    TILT Biotherapeutics Ltd
    Ultimovacs AS
    Vaxon Biotech

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
    ASTVAC-1
    ASTVAC-2
    ETS-2300
    Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Lung Cancer
    Ovarian Cancer
    Breast Cancer
    Others

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

EMEA (Europe, Middle East and Africa) Telomerase Reverse Transcriptase Market Report 2017
1 Telomerase Reverse Transcriptase Overview
    1.1 Product Overview and Scope of Telomerase Reverse Transcriptase
    1.2 Classification of Telomerase Reverse Transcriptase
        1.2.1 EMEA Telomerase Reverse Transcriptase Market Size (Sales) Comparison by Type (2012-2022)
        1.2.2 EMEA Telomerase Reverse Transcriptase Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 ASTVAC-1
        1.2.4 ASTVAC-2
        1.2.5 ETS-2300
        1.2.6 Others
    1.3 EMEA Telomerase Reverse Transcriptase Market by Application/End Users
        1.3.1 EMEA Telomerase Reverse Transcriptase Sales (Volume) and Market Share Comparison by Application (2012-2022
        1.3.2 Lung Cancer
        1.3.3 Ovarian Cancer
        1.3.4 Breast Cancer
        1.3.5 Others
    1.4 EMEA Telomerase Reverse Transcriptase Market by Region
        1.4.1 EMEA Telomerase Reverse Transcriptase Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 Europe Status and Prospect (2012-2022)
        1.4.3 Middle East Status and Prospect (2012-2022)
        1.4.4 Africa Status and Prospect (2012-2022)
    1.5 EMEA Market Size (Value and Volume) of Telomerase Reverse Transcriptase (2012-2022)
        1.5.1 EMEA Telomerase Reverse Transcriptase Sales and Growth Rate (2012-2022)
        1.5.2 EMEA Telomerase Reverse Transcriptase Revenue and Growth Rate (2012-2022)

2 EMEA Telomerase Reverse Transcriptase Competition by Manufacturers/Players/Suppliers, Region, Type and Application
    2.1 EMEA Telomerase Reverse Transcriptase Market Competition by Players/Manufacturers
        2.1.1 EMEA Telomerase Reverse Transcriptase Sales Volume and Market Share of Major Players (2012-2017)
        2.1.2 EMEA Telomerase Reverse Transcriptase Revenue and Share by Players (2012-2017)
        2.1.3 EMEA Telomerase Reverse Transcriptase Sale Price by Players (2012-2017)
    2.2 EMEA Telomerase Reverse Transcriptase (Volume and Value) by Type/Product Category
        2.2.1 EMEA Telomerase Reverse Transcriptase Sales and Market Share by Type (2012-2017)
        2.2.2 EMEA Telomerase Reverse Transcriptase Revenue and Market Share by Type (2012-2017)
        2.2.3 EMEA Telomerase Reverse Transcriptase Sale Price by Type (2012-2017)
    2.3 EMEA Telomerase Reverse Transcriptase (Volume) by Application
    2.4 EMEA Telomerase Reverse Transcriptase (Volume and Value) by Region
        2.4.1 EMEA Telomerase Reverse Transcriptase Sales and Market Share by Region (2012-2017)
        2.4.2 EMEA Telomerase Reverse Transcriptase Revenue and Market Share by Region (2012-2017)
        2.4.3 EMEA Telomerase Reverse Transcriptase Sales Price by Region (2012-2017)

3 Europe Telomerase Reverse Transcriptase (Volume, Value and Sales Price), by Players, Countries, Type and Application
    3.1 Europe Telomerase Reverse Transcriptase Sales and Value (2012-2017)
        3.1.1 Europe Telomerase Reverse Transcriptase Sales Volume and Growth Rate (2012-2017)
        3.1.2 Europe Telomerase Reverse Transcriptase Revenue and Growth Rate (2012-2017)
    3.2 Europe Telomerase Reverse Transcriptase Sales and Market Share by Type
    3.3 Europe Telomerase Reverse Transcriptase Sales and Market Share by Application
    3.4 Europe Telomerase Reverse Transcriptase Sales Volume and Value (Revenue) by Countries
        3.4.1 Europe Telomerase Reverse Transcriptase Sales Volume by Countries (2012-2017)
        3.4.2 Europe Telomerase Reverse Transcriptase Revenue by Countries (2012-2017)
        3.4.3 Germany Telomerase Reverse Transcriptase Sales and Growth Rate (2012-2017)
        3.4.4 France Telomerase Reverse Transcriptase Sales and Growth Rate (2012-2017)
        3.4.5 UK Telomerase Reverse Transcriptase Sales and Growth Rate (2012-2017)
        3.4.6 Russia Telomerase Reverse Transcriptase Sales and Growth Rate (2012-2017)
        3.4.7 Italy Telomerase Reverse Transcriptase Sales and Growth Rate (2012-2017)
        3.4.8 Benelux Telomerase Reverse Transcriptase Sales and Growth Rate (2012-2017)

4 Middle East Telomerase Reverse Transcriptase (Volume, Value and Sales Price), by Region, Type and Application
    4.1 Middle East Telomerase Reverse Transcriptase Sales and Value (2012-2017)
        4.1.1 Middle East Telomerase Reverse Transcriptase Sales Volume and Growth Rate (2012-2017)
        4.1.2 Middle East Telomerase Reverse Transcriptase Revenue and Growth Rate (2012-2017)
    4.2 Middle East Telomerase Reverse Transcriptase Sales and Market Share by Type
    4.3 Middle East Telomerase Reverse Transcriptase Sales and Market Share by Application
    4.4 Middle East Telomerase Reverse Transcriptase Sales Volume and Value (Revenue) by Countries
        4.4.1 Middle East Telomerase Reverse Transcriptase Sales Volume by Countries (2012-2017)
        4.4.2 Middle East Telomerase Reverse Transcriptase Revenue by Countries (2012-2017)
        4.4.3 Saudi Arabia Telomerase Reverse Transcriptase Sales and Growth Rate (2012-2017)
        4.4.4 Israel Telomerase Reverse Transcriptase Sales and Growth Rate (2012-2017)
        4.4.5 UAE Telomerase Reverse Transcriptase Sales and Growth Rate (2012-2017)
        4.4.6 Iran Telomerase Reverse Transcriptase Sales and Growth Rate (2012-2017)

5 Africa Telomerase Reverse Transcriptase (Volume, Value and Sales Price) by Players, Countries, Type and Application
    5.1 Africa Telomerase Reverse Transcriptase Sales and Value (2012-2017)
        5.1.1 Africa Telomerase Reverse Transcriptase Sales Volume and Growth Rate (2012-2017)
        5.1.2 Africa Telomerase Reverse Transcriptase Revenue and Growth Rate (2012-2017)
    5.2 Africa Telomerase Reverse Transcriptase Sales and Market Share by Type
    5.3 Africa Telomerase Reverse Transcriptase Sales and Market Share by Application
    5.4 Africa Telomerase Reverse Transcriptase Sales Volume and Value (Revenue) by Countries
        5.4.1 Africa Telomerase Reverse Transcriptase Sales Volume by Countries (2012-2017)
        5.4.2 Africa Telomerase Reverse Transcriptase Revenue by Countries (2012-2017)
        5.4.3 South Africa Telomerase Reverse Transcriptase Sales and Growth Rate (2012-2017)
        5.4.4 Nigeria Telomerase Reverse Transcriptase Sales and Growth Rate (2012-2017)
        5.4.5 Egypt Telomerase Reverse Transcriptase Sales and Growth Rate (2012-2017)
        5.4.6 Algeria Telomerase Reverse Transcriptase Sales and Growth Rate (2012-2017)

6 EMEA Telomerase Reverse Transcriptase Manufacturers/Players Profiles and Sales Data
    6.1 Argos Therapeutics Inc
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Telomerase Reverse Transcriptase Product Type, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Argos Therapeutics Inc Telomerase Reverse Transcriptase Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 Asterias Biotherapeutics Inc
        6.2.1 Company Basic Information, Manufacturing Base and Competitors
        6.2.2 Telomerase Reverse Transcriptase Product Type, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Asterias Biotherapeutics Inc Telomerase Reverse Transcriptase Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 e-Therapeutics Plc
        6.3.1 Company Basic Information, Manufacturing Base and Competitors
        6.3.2 Telomerase Reverse Transcriptase Product Type, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 e-Therapeutics Plc Telomerase Reverse Transcriptase Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 F. Hoffmann-La Roche Ltd
        6.4.1 Company Basic Information, Manufacturing Base and Competitors
        6.4.2 Telomerase Reverse Transcriptase Product Type, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 F. Hoffmann-La Roche Ltd Telomerase Reverse Transcriptase Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 Inovio Pharmaceuticals Inc
        6.5.1 Company Basic Information, Manufacturing Base and Competitors
        6.5.2 Telomerase Reverse Transcriptase Product Type, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Inovio Pharmaceuticals Inc Telomerase Reverse Transcriptase Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 Invectys SA
        6.6.1 Company Basic Information, Manufacturing Base and Competitors
        6.6.2 Telomerase Reverse Transcriptase Product Type, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Invectys SA Telomerase Reverse Transcriptase Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 Johnson & Johnson
        6.7.1 Company Basic Information, Manufacturing Base and Competitors
        6.7.2 Telomerase Reverse Transcriptase Product Type, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Johnson & Johnson Telomerase Reverse Transcriptase Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 Komipharm International Co Ltd
        6.8.1 Company Basic Information, Manufacturing Base and Competitors
        6.8.2 Telomerase Reverse Transcriptase Product Type, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 Komipharm International Co Ltd Telomerase Reverse Transcriptase Sales, Revenue, Price and Gross Margin (2012-2017)
        6.8.4 Main Business/Business Overview
    6.9 Mediolanum farmaceutici SpA
        6.9.1 Company Basic Information, Manufacturing Base and Competitors
        6.9.2 Telomerase Reverse Transcriptase Product Type, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 Mediolanum farmaceutici SpA Telomerase Reverse Transcriptase Sales, Revenue, Price and Gross Margin (2012-2017)
        6.9.4 Main Business/Business Overview
    6.10 Telocyte LLC
        6.10.1 Company Basic Information, Manufacturing Base and Competitors
        6.10.2 Telomerase Reverse Transcriptase Product Type, Application and Specification
            6.10.2.1 Product A
            6.10.2.2 Product B
        6.10.3 Telocyte LLC Telomerase Reverse Transcriptase Sales, Revenue, Price and Gross Margin (2012-2017)
        6.10.4 Main Business/Business Overview
    6.11 TILT Biotherapeutics Ltd
    6.12 Ultimovacs AS
    6.13 Vaxon Biotech

7 Telomerase Reverse Transcriptase Manufacturing Cost Analysis
    7.1 Telomerase Reverse Transcriptase Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Telomerase Reverse Transcriptase

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Telomerase Reverse Transcriptase Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Telomerase Reverse Transcriptase Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 EMEA Telomerase Reverse Transcriptase Market Forecast (2017-2022)
    11.1 EMEA Telomerase Reverse Transcriptase Sales, Revenue and Price Forecast (2017-2022)
        11.1.1 EMEA Telomerase Reverse Transcriptase Sales and Growth Rate Forecast (2017-2022)
        11.1.2 EMEA Telomerase Reverse Transcriptase Revenue and Growth Rate Forecast (2017-2022)
        11.1.3 EMEA Telomerase Reverse Transcriptase Price and Trend Forecast (2017-2022)
    11.2 EMEA Telomerase Reverse Transcriptase Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.3 Europe Telomerase Reverse Transcriptase Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.4 Middle Eastt Telomerase Reverse Transcriptase Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.5 Africa Telomerase Reverse Transcriptase Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.6 EMEA Telomerase Reverse Transcriptase Sales Forecast by Type (2017-2022)
    11.7 EMEA Telomerase Reverse Transcriptase Sales Forecast by Application (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer